Recombinant FOLR1 (Farletuzumab Biosimilar) antibody

Catalog No. ABIN7597684

The Humanized Chimeric anti-FOLR1 (Farletuzumab Biosimilar) antibody has been validated for . It is suitable to detect FOLR1 (Farletuzumab Biosimilar) in samples from Human.

Quick Overview for Recombinant FOLR1 (Farletuzumab Biosimilar) antibody (ABIN7597684)

Target: FOLR1 (Farletuzumab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Humanized

Clonality: Chimeric

Conjugate: This FOLR1 (Farletuzumab Biosimilar) antibody is un-conjugated

Application: Please inquire

Grade: Research Grade

Product Details anti-FOLR1 (Farletuzumab Biosimilar) Antibody

Expression System: Mammalian cells

Purpose: Research Grade Farletuzumab Biosimilar Antibody

Specificity: Folate receptor alpha, FOLR, FOLR1, Adult folate-binding protein, Folate receptor 1, FR-alpha, KB cells FBP, FBP, Ovarian tumor-associated antigen MOv18, Folate receptor, adult

Purification: Protein A or G purified from cell culture supernatant.

Purity: >95 % by SDS-PAGE.

Isotype: IgG1 kappa

Application Details

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: 1 mg/mL

Buffer: 0.01M PBS, pH 7.4.

Storage: 4 °C,-20 °C,-80 °C

Storage Comment: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.

Expiry Date: 12 months

Target Details for FOLR1 (Farletuzumab Biosimilar)

Target: FOLR1 (Farletuzumab Biosimilar)

Alternative Name: Farletuzumab Biosimilar

Target Type: Biosimilar

Background: Folate receptor alpha, FOLR, FOLR1, Adult folate-binding protein, Folate receptor 1, FR-alpha, KB cells FBP, FBP, Ovarian tumor-associated antigen MOv18, Folate receptor, adult

UniProt: P15328

CAS-No: 896723-44-7